ARCHIVES

MEPACT Approved In Europe For Resectable Osteosarcoma

This article is from The Cancer Letter archive.

Vol. 32 No. 3 | March 27, 2009

Download PDF Visit The Full Archive

Related Articles

Waksal To Pay Back $800,000 In Profits From Stock Sales

March 14, 2003

Treat Cancer, But Protect Heart Anderson Cardiologists Warn

July 30, 2004

Research Funding In Crisis; Scientists Fear Cancer Program’s Dismantling, AACR Says

January 20, 1995

“If We Had More Resources, It’s A Fantastic Time” For Cancer Research

May 12, 1995

UPCI Puts the Cancer Letter on its Intranet for Employees

May 5, 2000

IPRI’s Peter Boyle on Closing the Gap In Global Cancer Treatment And Outcomes

January 31, 2014